InvestorsHub Logo
Followers 87
Posts 6693
Boards Moderated 1
Alias Born 09/18/2009

Re: eb0783 post# 40342

Thursday, 08/17/2023 4:33:16 AM

Thursday, August 17, 2023 4:33:16 AM

Post# of 42926
Thanks, eb. The subject of lenzilumab restoring the immune response system is developing in our trial data. I think it is hugely important, and will become even more so.

But, the covid re-infection rate in lenz patients is also something I have long thought is hugely important, and I don't see any data on that yet, after all this time.

I'm looking forward to learning more on both subjects. I'd even like to have the raw data to be able to make those determinations, if it is not something that is being analyzed.